BR112012031444A2 - método, arranjo e uso do mesmo - Google Patents

método, arranjo e uso do mesmo

Info

Publication number
BR112012031444A2
BR112012031444A2 BR112012031444A BR112012031444A BR112012031444A2 BR 112012031444 A2 BR112012031444 A2 BR 112012031444A2 BR 112012031444 A BR112012031444 A BR 112012031444A BR 112012031444 A BR112012031444 A BR 112012031444A BR 112012031444 A2 BR112012031444 A2 BR 112012031444A2
Authority
BR
Brazil
Prior art keywords
biomarkers
proteome
sample
individual
amount
Prior art date
Application number
BR112012031444A
Other languages
English (en)
Portuguese (pt)
Inventor
Carl Arne Krister Borrebaeck
Christer Lars Bertil Wingren
Original Assignee
Immunovia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia Ab filed Critical Immunovia Ab
Publication of BR112012031444A2 publication Critical patent/BR112012031444A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112012031444A 2010-06-11 2011-06-09 método, arranjo e uso do mesmo BR112012031444A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1009798.8A GB201009798D0 (en) 2010-06-11 2010-06-11 Method,array and use thereof
PCT/GB2011/000865 WO2011154698A2 (en) 2010-06-11 2011-06-09 Method,array and use thereof

Publications (1)

Publication Number Publication Date
BR112012031444A2 true BR112012031444A2 (pt) 2016-10-25

Family

ID=42471508

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012031444A BR112012031444A2 (pt) 2010-06-11 2011-06-09 método, arranjo e uso do mesmo

Country Status (11)

Country Link
US (2) US20130143760A1 (https=)
EP (1) EP2580592B1 (https=)
JP (1) JP6104796B2 (https=)
CN (1) CN103038642B (https=)
AU (1) AU2011263533B2 (https=)
BR (1) BR112012031444A2 (https=)
CA (1) CA2801863A1 (https=)
ES (1) ES2608956T3 (https=)
GB (1) GB201009798D0 (https=)
IN (1) IN2013CN00297A (https=)
WO (1) WO2011154698A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
US10928402B2 (en) 2012-12-28 2021-02-23 Nx Prenatal Inc. Treatment of spontaneous preterm birth
AU2015263998A1 (en) * 2014-05-22 2016-12-08 Northwestern University Gene expression profiles associated with sub-clinical kidney transplant rejection
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
BR112017007962A2 (pt) * 2014-10-24 2018-01-23 Koninklijke Philips Nv método implementado por computador, aparelho, mídia de armazenamento, programa de computador, kit, e, uso do kit
CA2976947C (en) * 2015-02-18 2023-02-28 Siemens Healthcare Diagnostics Inc. Locality-based detection of tray slot types and tube types in a vision system
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
WO2017096405A1 (en) * 2015-12-04 2017-06-08 Nx Prenatal Inc. Use of circulating microparticles to stratify risk of spontaneous preterm birth
CN109444402B (zh) * 2018-12-18 2021-05-28 郑州安图生物工程股份有限公司 去甲肾上腺素发光免疫检测试剂盒

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12586T1 (de) 1980-05-02 1985-04-15 Edward P Davis Beinentlastungsgeraet.
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US5376531A (en) 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
EP1876241A3 (en) 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
RO114835B1 (ro) 1997-03-17 1999-07-30 Ioan Puşcaş Metodă rapidă de diagnostic al cancerelor
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
AUPP525198A0 (en) 1998-08-13 1998-09-03 Medvet Science Pty. Ltd. Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof
US6492505B1 (en) 1999-02-01 2002-12-10 Incyte Genomics, Inc. Composition for detection of genes encoding membrane-associated proteins
WO2002101357A2 (en) 2001-06-10 2002-12-19 Irm Llc Molecular signatures of commonly fatal carcinomas
AU2003284880A1 (en) 2002-10-24 2004-05-13 Duke University Evaluation of breast cancer states and outcomes using gene expression profiles
US20040087571A1 (en) 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040259161A1 (en) 2003-03-12 2004-12-23 Fredrik Nilsson Screening assay
WO2004106495A2 (en) 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20060019256A1 (en) 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
ATE491953T1 (de) * 2003-09-15 2011-01-15 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
JP4443568B2 (ja) 2003-10-15 2010-03-31 エフ．ホフマン−ラ ロシュ アーゲー 乳癌に対するマーカーとしてのタンパク質ａｓｃの使用
WO2005080570A1 (ja) 2004-02-24 2005-09-01 Mitsubishi Rayon Co., Ltd. 乳癌の術後予後予測に関与する遺伝子
US20090166224A1 (en) 2004-05-05 2009-07-02 Ziping Yang Multi-lectin affinity chromatography and uses thereof
WO2006105642A1 (en) 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
WO2007002069A2 (en) 2005-06-21 2007-01-04 Anthony Goncalves Serum biomarkers for breast cancer
US7972770B2 (en) 2005-08-16 2011-07-05 Memorial Sloan-Kettering Cancer Center Methods of detection of cancer using peptide profiles
EP1777523A1 (en) 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
US20080311601A1 (en) 2005-11-02 2008-12-18 Elting James J Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
US9095549B2 (en) * 2005-12-16 2015-08-04 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
SG142186A1 (en) 2006-10-20 2008-05-28 Agency Science Tech & Res Breast tumour grading
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
NZ562237A (en) 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
GB0723179D0 (en) 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
US20090239229A1 (en) * 2008-03-14 2009-09-24 Dnar, Inc DNA Repair Proteins Associated With Triple Negative Breast Cancers and Methods of Use Thereof
EP2105740A1 (en) * 2008-03-28 2009-09-30 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. Biomarkers for monitoring or predicting the treatment of cancer
EP2281063B1 (en) 2008-04-29 2014-10-15 Siemens Healthcare Diagnostics GmbH A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
JP2010151800A (ja) 2008-11-06 2010-07-08 Kumamoto Univ 生活習慣病及び／又は癌の診断剤
WO2010076322A1 (en) 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer
EP2391962B1 (en) 2009-01-28 2016-12-21 University of Notre Dame du Lac Accelerated progression relapse test
MX337650B (es) 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
GB201410226D0 (en) 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same

Also Published As

Publication number Publication date
CN103038642A (zh) 2013-04-10
EP2580592A2 (en) 2013-04-17
WO2011154698A8 (en) 2013-01-17
AU2011263533B2 (en) 2016-11-03
US10564163B2 (en) 2020-02-18
AU2011263533A8 (en) 2013-03-21
AU2011263533A1 (en) 2013-01-10
EP2580592B1 (en) 2016-10-05
US20180313852A1 (en) 2018-11-01
IN2013CN00297A (https=) 2015-07-03
WO2011154698A2 (en) 2011-12-15
JP2013529773A (ja) 2013-07-22
CN103038642B (zh) 2017-02-22
CA2801863A1 (en) 2011-12-15
ES2608956T3 (es) 2017-04-17
WO2011154698A3 (en) 2012-03-01
JP6104796B2 (ja) 2017-03-29
US20130143760A1 (en) 2013-06-06
GB201009798D0 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
BR112012031444A2 (pt) método, arranjo e uso do mesmo
BR112012011230A2 (pt) fatores de risco e previsão de infarto do miocárdio
ATE554389T1 (de) Apex als marker für lungenkrebs
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
WO2015067969A3 (en) Method, array and use thereof for determining pancreatic cancer
WO2012061759A3 (en) Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
WO2014083427A3 (en) Compositions and methods for detecting vitamin d
BR112014006432B8 (pt) Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador
BRPI0515562A (pt) métodos e composições para avaliação do prognóstico do cáncer de mama
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
JP2013529773A5 (https=)
EP3907509A3 (en) Diagnosis of early stage pancreatic cancer
Adam-Artigues et al. Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer
WO2019074615A3 (en) In vitro methods for skin therapeutic compound discovery using skin age biomarkers
GB201207297D0 (en) Analytical methods and arrays for use in the same
BR112016007037A2 (pt) método para detectar câncer pancreático, anticorpo monoclonal e kit
WO2019055661A8 (en) Preeclampsia biomarkers and related systems and methods
BR112015010399A2 (pt) método e kit para a determinação de cobre livre no soro
WO2012050365A3 (ko) 교모세포종의 진단 또는 예후 예측용 바이오 마커 및 그 용도
WO2015091575A3 (en) Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer
MY195697A (en) Method of Prognosing and Predicting Breast Cancer Recurrence, Markers Employed Therein and Kit Thereof
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2517 DE 02-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.